Investors were surely discovering drug discovery company AbCellera Biologics ( ABCL 6.19%) as the trading week kicked off on ...

On Monday morning, Genmab announced a set of phase 1/2 clinical trial results for its rinatabart sesutecan (Rina-S) drug, which it's developing for a type of uterine cancer. The company said the drug ...